The Global Cancer Gene Therapy Market  was valued at US$ 2.1 billion in 2023 and is projected to reach US$ 7.8 billion by 2031, registering a CAGR of 17.5% during the forecast period 2024–2031. Market growth is primarily driven by the increasing prevalence of cancer worldwide, coupled with the growing demand for targeted and personalized treatment modalities beyond conventional...